DOACs Offered After Heart Valve Surgery Despite Absence of Data

Direct oral anticoagulants (DOACs) are used in about 1% of patients undergoing surgical mechanical aortic and mitral valve replacement, but in up to 6% of surgical bioprosthetic valve replacements, according to registry data presented at CRT 2021. In an analysis of the Society of Thoracic Surgery (STS) registry during 2014–2017, DOAC use increased steadily among those undergoing surgical bioprosthetic valve […]
Continue reading »